ArticleBritish journal of cancer2012

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

M C Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.